10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $342,128 | -34.7% | 8,294 | -11.6% | 0.72% | -11.5% |
| Q2 2023 | $523,891 | -8.4% | 9,382 | -8.5% | 0.81% | -2.9% |
| Q1 2023 | $571,848 | +35.8% | 10,250 | -11.3% | 0.84% | +55.8% |
| Q4 2022 | $420,991 | +0.7% | 11,553 | -21.3% | 0.54% | +30.4% |
| Q3 2022 | $418,000 | -16.2% | 14,678 | +33.1% | 0.41% | -10.5% |
| Q2 2022 | $499,000 | -25.0% | 11,029 | +26.2% | 0.46% | +27.1% |
| Q1 2022 | $665,000 | -56.2% | 8,737 | -14.3% | 0.36% | -31.6% |
| Q4 2021 | $1,519,000 | -27.9% | 10,197 | -29.6% | 0.53% | -25.1% |
| Q3 2021 | $2,108,000 | -18.0% | 14,478 | +10.2% | 0.70% | -25.2% |
| Q2 2021 | $2,572,000 | +11.2% | 13,133 | +2.8% | 0.94% | -8.5% |
| Q1 2021 | $2,312,000 | – | 12,773 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |